Navigation Links
Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
Date:9/12/2007

Defendant Brings Infringement Action

LIVINGSTON, N.J., Sept. 12 /PRNewswire-FirstCall/ -- Milestone Scientific, Inc. (OTC Bulletin Board: MLSS) today announced that on August 24, 2007 it commenced a Declaratory Judgment Action against Milton Hodosh, DMD in the United States District Court for the District of New Jersey seeking a determination by that Court that neither its Single Tooth Anesthesia (STA(TM)) system nor its CompuDent(TM) system infringed claims set forth in United States Patent No. 6159161 filed by Dr. Hodosh on July 8, 1998 and issued by the United States Patent Office on December 12, 2000. Milestone's basic patents covering these systems were issued by the United States Patent Office in January 1993. Subsequent to the commencement of Milestone's action for a Declaratory Judgment, Dr. Hodosh commenced a patent infringement suit in the United States District Court for the Southern District of New York. Milestone has received opinions from patent counsel, not involved in the litigations, to the effect that neither the STA(TM) system nor the Compudent(TM) system infringe any of the claims of Dr. Hodosh's patents. Milestone believes that it has meritorious defenses to Dr. Hodosh's action and it intends to vigorously defend this law suit. Issue has not yet been joined in either action and Milestone's counsel is considering whether or not it will seek to consolidate these actions which, essentially, deal with the same subject matter.

About Milestone Scientific, Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved delivery of local anesthetic below a patient's threshold of pain. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion
'/>"/>

SOURCE Milestone Scientific, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Cancer Research: Yet Another Milestone
2. Eurand and GSK Reach Development Milestone
3. Year 2010 Envisioned to be Milestone Year for Malaria Vaccine
4. A New Milestone in Stem Cell Research
5. Scientific markers of aging described
6. A Settlement Over Stem Cell Controversy Through Scientific Research
7. A Scientific Explanation For Out Of Body Experience
8. PUFA Good For Heart: Gets The Scientific Seal
9. Forensic Phonetics – Scientific Solution for Legal Problem
10. Old Indian Advice Has A Scientific Backing Now!
11. India To Highlight Its Scientific Achievements

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--TheBayAreaAirQualityManagementDistrictisissui... Alert forThursday,November26,2009whichbansburn...thindoorsandoutdoors. ,, "Cold,stillweatherwill...roadbent,executiveofficeroftheAirDistrict."We,reas...borsandfellowcommunitymembersthisThanksgiving,andn...
(Date:11/25/2009)...cancer who were treated with cisplatin-based chemo...urological side effects and Raynaud-like phenomena... according to a new study published online Novembe...ute . , Marianne Brydy, M.D., of the Department ...gen, Norway, and colleagues conducted a cross-sect...
(Date:11/25/2009)... out of a collaboration between UCLA engineers and...arly 10 million Americans who suffer from peripher...ng of the arteries, peripheral arterial disease, o...rrowed arteries reduce blood flow to the limbs. Th...disease, heart attack and stroke, and its progress...
(Date:11/25/2009)...hort to draw definite conclusions, experts say, ,...- In diabetic patients with blocked coronary arter... at one year whether patients undergo bypass surge...rs report. , Bypass surgery has been the standa...rtery disease. However, less invasive approaches s...
(Date:11/25/2009)... and treatment clinics to resume Monday, Nov. 30 ...er 25, 2009 -- Centegra Health System is continuin...ots at four Centegra Primary Care (CPC) vaccinatio...rived. The clinics are at CPC sites in Huntley, Wo... as follows: ,   From 4:30 to 7:30 p.m...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... Bias Correction of Familial Risk Estimates Incr...r Common Cancers , The relative risk of familial... account for a known potential bias in a large coh... have used the Swedish Cancer Registry and the Swe...
...espite recommendations from various groups, many h... TUESDAY, Sept. 9 (HealthDay News) -- According to... report giving formula sample packs to new moms, e... Adolescent Medicine , surveyed 1,295 hospitals in...
...EXFORD, Penn., Sept. 9 Millennium Pharmacy System...hnology enabled pharmacy,solutions to senior healt...of Richard Scardina as Chief Executive Officer. Mr...erving as an executive,with Caremark Rx, Inc., Ga...
... PHILADELPHIA - Researchers from the University o...a key step in the formation and suppression of e...east, head, and neck. By studying human tissue sam...t to contribute to the early stages of cancer deve...
...THENS, Ga., Sept. 9 ArunA Biomedical, Inc., the f... cell derived products and,services, announced tod...ion CFO, Harold "Bud" Ingalls, to its Board of Dir...arly 20 years of experience as a chief financial o...
...lan Challenges Policy-makers, Physicians, Patients...SHINGTON, Sept. 9 In an address today at,the Nati...E: MHS ) Chairman,and CEO, David B. Snow Jr. unve... problem. Unifying the strengths,of both the publi...
Other Medicine News:Health News:Also in the Sept. 9 JNCI 2Health News:Also in the Sept. 9 JNCI 3Health News:Formula Samples Hinder Breast-Feeding Efforts 2Health News:Penn researchers identify natural tumor suppressor 2Health News:ArunA Biomedical Names Harold Ingalls to its Board of Directors 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 3Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 4
(Date:11/25/2009)...ndsResearchGroup,Inc.releasedWave1ofits LaunchTre...syndicatedmarketresearchprojecttrackingthelaunchof...roughthefirstsixmonthsofavailability.Eachwaveofthe...ermatologistsandqualitativeinformationfromasubseto...touse,typicalpatienttypes,productperceptions,promo...
(Date:11/25/2009)...--RegadoBiosciences,aprivatelyheldcompanyleadingth...rolagents,announcedthatDavidMazzo,PhD,CEOandPresid...lthCareConferenceattheNewYorkPalaceHotelinNewYorkC...onTuesday,December1andwillincludeanoverviewoftheCo...gram,theanticoagulantsystem,REG1.Thehealthcareindu...
(Date:11/25/2009).../--SwissrayInternational,Inc.aleadingmanufacturero...odaythatitsoperationshavebeenacquiredbyaprivateSwi...smedicalimagingbrand.Theacquisitionincludedallasse...ntory.After25yearsofsuccessandgrowthSwissrayisnowp...tswithstableandsteadygrowth. ,, "Swissrayhaslon...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2SpectraScience Receives FDA Approval for Enhancements to WavSTAT 28R 29 Optical Biopsy System 57419 1SpectraScience Receives FDA Approval for Enhancements to WavSTAT 28R 29 Optical Biopsy System 57419 2Scars of Bullying Linger 57417 1InVitria Cell Culture Product Line to Headline PEACe 57415 1InVitria Cell Culture Product Line to Headline PEACe 57415 2
... Agennix Incorporated today announced,the publica...rial with,talactoferrin alfa in patients who had f...c renal cell carcinoma (RCC). Results from the stu...journal ,Cancer, (volume,113, number 1), demonstra...rable toxicity profile, and is a promising candida...
...innon, Founder of HEAR Music, NEW YORK, June 30 ...eamless way for people to receive music from artis...h (RED). By applying the (RED),idea to music this ...ists,and labels and buy life-saving medicine for t...founder of HEAR Music and former Vice President of...
Other Medicine Technology:Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 2Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 4Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 5(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 2(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 3
Streck-Kleen Concentrate Enzymatic Cleanser
Streck-CD3500 Hemoglobin/Lyse Lytic Reagent
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-Diluent IIIA Balanced Electrolyte Solution
Medicine Products: